Can thiamine substitution restore cognitive function in alcohol use disorder?

Aims While clinical consequences of thiamine deficiency in alcohol use disorder (AUD) are severe, evidence-based recommendations on dosage, type of administration and duration of thiamine substitution (TS), and its' target levels remain sparse. This study aimed to compare the effect of two best prac...

Descripción completa

Detalles Bibliográficos
Publicado en:Alcohol & Alcoholism Vol. 58; no. 3; pp. 315 - 324
Autores principales: Listabarth, Stephan, Vyssoki, Benjamin, Marculescu, Rodrig, Gleiss, Andreas, Groemer, Magdalena, Trojer, Armin, Harrer, Christine, Weber, Sabine, König, Daniel
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA May2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163720434&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163720434
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07350414
        FA3
      jtl: Alcohol & Alcoholism
      issn: 07350414
      maglogo: N
    pubinfo:
      dt: May2023
      vid: 58
      iid: 3
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        163720434
        163720434
        163720434
        10.1093/alcalc/agad017
        163720434
      ppf: 315
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Can thiamine substitution restore cognitive function in alcohol use disorder?
      aug:
        au:
          Listabarth, Stephan
          Vyssoki, Benjamin
          Marculescu, Rodrig
          Gleiss, Andreas
          Groemer, Magdalena
          Trojer, Armin
          Harrer, Christine
          Weber, Sabine
          König, Daniel
        affil: Clinical Division of Social Psychiatry , Department of Psychiatry and Psychotherapy, Medical University of Vienna , 1090 Vienna , Austria
      sug:
        subj:
          Alcohol-Related Disorders Drug Therapy
          Thiamine Administration and Dosage
          Cognition
          Functional Status
          Treatment Outcomes Evaluation
          Medical Practice
          Human
          Funding Source
          Treatment Duration
          Thiamine Deficiency Complications
          Thiamine Blood
          Comparative Studies
          Inpatients
          Blood Analysis
          Confidence Intervals
          Memory
          Task Performance and Analysis
          Alcohol-Related Disorders Complications
          Dementia Prevention and Control
          Cognition Disorders Prevention and Control
          Korsakoff Syndrome
          Wernicke's Encephalopathy
      ab: Aims While clinical consequences of thiamine deficiency in alcohol use disorder (AUD) are severe, evidence-based recommendations on dosage, type of administration and duration of thiamine substitution (TS), and its' target levels remain sparse. This study aimed to compare the effect of two best practice TS regimens on thiamine blood levels (i.e. thiamine pyrophosphate, TPP) and cognitive function. Methods In 50 patients undergoing in-patient alcohol-withdrawal treatment, TPP levels were determined at baseline and end of weeks 1, 2 and 8 following administration of oral TS (3 × 100 mg/day for 7 days followed by 1 × 100 mg/day thereafter) either with or without preceding intravenous TS (3 × 100 mg/day for 5 days). An extensive psychiatric assessment was conducted at baseline, including an evaluation of AUD severity and depressive symptoms. Additionally, cognitive function and depressive symptoms were repeatedly evaluated. Results Relevant increases (mean increase by 100.2 nmol/l [CI 76.5–123.8], P  < 0.001) in peripheral blood TPP levels were observed in all patients at the end of weeks 1 and 2. Furthermore, no relevant difference between the intravenous and the oral group was found (average difference between increases: 2.3 nmol/l, P  = 0.912). Importantly, an association between the 'extent of the response' to TS and the performance in a memory task was revealed in secondary analyses. Conclusion TS was associated with improving cognitive function in patients with AUD, independently of the substitution regime. Thus, in clinical practice, oral TS might be a sufficient but obligatory medication to prevent cognitive decline in AUD in the absence of Wernicke–Korsakoff Syndrome.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N